Tvardi Therapeutics, Inc. (TVRD) Form 10-Q Quarterly Reports
Tvardi Therapeutics, Inc. (TVRD) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TVRD
CIK: 1346830
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerKelly Redding
Audit LocationHouston, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001104659-26-096424 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | FORM 8-K | 0001104659-26-096417 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | FORM 8-K | 0001104659-26-088461 | View SEC Doc Filr Page |
| 8-K | 2026-07-17 | 2026-07-17 | FORM 8-K | 0001104659-26-084627 | View SEC Doc Filr Page |
| 424B5 | 2026-07-17 | — | 424B5 | 0001104659-26-084619 | View SEC Doc Filr Page |
| 8-K | 2026-07-07 | 2026-07-07 | FORM 8-K | 0001104659-26-080930 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 Filing | 0001811463-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 Filing | 0001609480-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 Filing | 0001588861-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 Filing | 0001762801-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 Filing | 0001201256-26-000003 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-09 | FORM 8-K | 0001104659-26-072930 | View SEC Doc Filr Page |
| EFFECT | 2026-05-13 | — | EFFECT Filing | 9999999995-26-001601 | View SEC Doc Filr Page |
| EFFECT | 2026-05-12 | — | EFFECT Filing | 9999999995-26-001593 | View SEC Doc Filr Page |
| POS AM | 2026-05-08 | — | POS AM | 0001104659-26-057914 | View SEC Doc Filr Page |
| CORRESP | 2026-05-08 | — | CORRESP Filing | 0001104659-26-057883 | View SEC Doc Filr Page |
| 10-Q | 2026-05-08 | 2026-03-31 | 10-Q | 0001104659-26-057528 | View SEC Doc Filr Page |
| 8-K | 2026-05-08 | 2026-05-08 | FORM 8-K | 0001104659-26-057524 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-07 | — | UPLOAD Filing | 0000000000-26-004698 | View SEC Doc Filr Page |
| S-3 | 2026-05-01 | — | S-3 | 0001104659-26-054113 | View SEC Doc Filr Page |
| ARS | 2026-04-23 | 2025-12-31 | ARS | 0001104659-26-047713 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-23 | — | DEFA14A | 0001104659-26-047700 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-23 | 2026-06-09 | DEF 14A | 0001104659-26-047695 | View SEC Doc Filr Page |
| S-8 | 2026-04-01 | — | FORM S-8 | 0001104659-26-038133 | View SEC Doc Filr Page |
| POS EX | 2026-04-01 | — | POS EX | 0001104659-26-038128 | View SEC Doc Filr Page |